Literature DB >> 19099282

[Ten years' experience at a major stroke center].

T Konatschnig1, A Knöll, A Hug, W Hacke, P Ringleb.   

Abstract

BACKGROUND: About 1,300 stroke patients from a primarily rural area are treated each year at the Department of Neurology of the University Hospital of Heidelberg, Germany. Demographic and treatment data of all stroke patients there were prospectively collected. In a retrospective study we report on the changes in this patient population from 1996 to 2006, with special consideration of those suitable for intravenous thrombolysis.
METHODS: For all stroke patients the basic data were collected--age, sex, type of stroke (transient ischemic attack, stroke, or intracerebral hemorrhage), NIH Stroke Scale, duration between symptom onset and hospital arrival, delay between arrival and first doctor's contact, patient's further whereabouts, and for patients treated by iv thrombolysis, start of treatment and dosage.
RESULTS: There were no changes in the total number of stroke patients and median stroke severity, according to the NIH Stroke Scale, from 1996 to 2006. The proportion of stroke patients admitted within the first 3 h after symptom onset increased from 12.1% (1996) to 21.9% (2006). Thus we managed to treat 10.1% of all our ischemic stroke patients with iv thrombolysis, which means 39% of those patients with cerebral infarction arriving within 3 h. DISCUSSION: During the study period there were no significant changes in the patients' sociodemographic data. By consistent reduction of prehospital delay, the number of stroke patients that could be treated acutely by intravenous thrombolysis was increased.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19099282     DOI: 10.1007/s00115-008-2603-2

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  15 in total

1.  The unchanging incidence and case-fatality of stroke in the 1990s: a population-based study.

Authors:  Dawn Kleindorfer; Joseph Broderick; Jane Khoury; Matthew Flaherty; Daniel Woo; Kathleen Alwell; Charles J Moomaw; Alexander Schneider; Rosie Miller; Rakesh Shukla; Brett Kissela
Journal:  Stroke       Date:  2006-08-31       Impact factor: 7.914

2.  Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.

Authors:  Nils Wahlgren; Niaz Ahmed; Antoni Dávalos; Gary A Ford; Martin Grond; Werner Hacke; Michael G Hennerici; Markku Kaste; Sonja Kuelkens; Vincent Larrue; Kennedy R Lees; Risto O Roine; Lauri Soinne; Danilo Toni; Geert Vanhooren
Journal:  Lancet       Date:  2007-01-27       Impact factor: 79.321

3.  Barriers to stroke thrombolysis in a geographically defined population.

Authors:  S T Engelter; M Gostynski; S Papa; V Ajdacic-Gross; P A Lyrer
Journal:  Cerebrovasc Dis       Date:  2006-12-01       Impact factor: 2.762

4.  MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study.

Authors:  Martin Köhrmann; Eric Jüttler; Jochen B Fiebach; Hagen B Huttner; Stefan Siebert; Christian Schwark; Peter A Ringleb; Peter D Schellinger; Werner Hacke
Journal:  Lancet Neurol       Date:  2006-08       Impact factor: 44.182

5.  A prospective community-based study of stroke in Germany--the Erlangen Stroke Project (ESPro): incidence and case fatality at 1, 3, and 12 months.

Authors:  P L Kolominsky-Rabas; C Sarti; P U Heuschmann; C Graf; S Siemonsen; B Neundoerfer; A Katalinic; E Lang; K G Gassmann; T R von Stockert
Journal:  Stroke       Date:  1998-12       Impact factor: 7.914

6.  William M. Feinberg Lecture: stroke therapy in the year 2025: burden, breakthroughs, and barriers to progress.

Authors:  Joseph P Broderick
Journal:  Stroke       Date:  2003-12-11       Impact factor: 7.914

7.  A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects.

Authors:  Philippa C Lavallée; Elena Meseguer; Halim Abboud; Lucie Cabrejo; Jean-Marc Olivot; Olivier Simon; Mikael Mazighi; Chantal Nifle; Philippe Niclot; Bertrand Lapergue; Isabelle F Klein; Eric Brochet; Philippe Gabriel Steg; Guy Lesèche; Julien Labreuche; Pierre-Jean Touboul; Pierre Amarenco
Journal:  Lancet Neurol       Date:  2007-11       Impact factor: 44.182

8.  Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

Authors:  Werner Hacke; Geoffrey Donnan; Cesare Fieschi; Markku Kaste; Rüdiger von Kummer; Joseph P Broderick; Thomas Brott; Michael Frankel; James C Grotta; E Clarke Haley; Thomas Kwiatkowski; Steven R Levine; Chris Lewandowski; Mei Lu; Patrick Lyden; John R Marler; Suresh Patel; Barbara C Tilley; Gregory Albers; Erich Bluhmki; Manfred Wilhelm; Scott Hamilton
Journal:  Lancet       Date:  2004-03-06       Impact factor: 79.321

9.  R1--systemic thrombolysis in German stroke units--the experience from the German Stroke data bank.

Authors:  J Schenkel; C Weimar; T Knoll; R L Haberl; O Busse; G F Hamann; H-C Koennecke; H-C Diener
Journal:  J Neurol       Date:  2003-03       Impact factor: 4.849

10.  A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack.

Authors:  P M Rothwell; M F Giles; E Flossmann; C E Lovelock; J N E Redgrave; C P Warlow; Z Mehta
Journal:  Lancet       Date:  2005 Jul 2-8       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.